Page last updated: 2024-10-31

nalidixic acid and Infections, Yersinia

nalidixic acid has been researched along with Infections, Yersinia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, Y1
Michael, GB1
Becker, R1
Kaspar, H1
Mankertz, J1
Schwarz, S1
Runge, M1
Steinhagen, D1
Sánchez-Céspedes, J1
Navia, MM1
Martínez, R1
Orden, B1
Millán, R1
Ruiz, J2
Vila, J2
Capilla, S2
Goñi, P2
Rubio, MC2
Castillo, J2
Millán, L1
Cerdá, P1
Sahagún, J1
Pitart, C1
Beltrán, A1
Gómez-Lus, R2
Jiménez de Anta, MT1

Other Studies

4 other studies available for nalidixic acid and Infections, Yersinia

ArticleYear
Pheno- and genotypic analysis of antimicrobial resistance properties of Yersinia ruckeri from fish.
    Veterinary microbiology, 2014, Jul-16, Volume: 171, Issue:3-4

    Topics: Animals; Anti-Infective Agents; Aquaculture; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; F

2014
Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:4

    Topics: Anti-Infective Agents; Base Sequence; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial;

2003
Epidemiological study of resistance to nalidixic acid and other antibiotics in clinical Yersinia enterocolitica O:3 isolates.
    Journal of clinical microbiology, 2003, Volume: 41, Issue:10

    Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Ac

2003
Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:6

    Topics: Anti-Infective Agents; Ciprofloxacin; Dipeptides; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance,

2004